MIRA workshop 2025 – Partners & Sponsors
Join us in shaping the future of global health, support the MIRA Workshop 2025 and be a catalyst for transformative discoveries!
All ready supported by:
Partners and sponsors of our event
Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA) is a model for international collaborative research in advanced areas of Science & Technology. The Centre was established in 1987 and is being supported by the Department of Science & Technology, Government of India and the Ministry for Europe & Foreign Affairs, Government of France. CEFIPRA is actively involved in supporting Indo-French Science, Technology & Innovation (ST&I) system and promoting collaborative research through various activities.
The French Embassy in India, based in New Delhi, plays a key role in strengthening bilateral relations between France and India across political, economic, scientific, educational, and cultural fields. As part of its mission to foster French-Indian collaboration, the Embassy actively supports initiatives that promote scientific and academic cooperation between institutions, researchers and experts from both countries. It especially encourages joint projects that contribute to research and innovation in the face of today’s global challenges.
The IPBS hosts more than 250 scientific and administrative staff, including more than 60 PhD students and postdoctoral fellows of multiple nationalities, who work in a stimulating and highly collaborative environment. The IPBS currently comprises 18 research groups working in two broad research areas: the biology of tissue and cellular microenvironments, and the molecular and structural mechanisms of disease. Four facilities provide state-of-the-art technology in proteomics, biophysics and structural biology, molecular and cellular imaging, and functional exploration. Several BSL-3 laboratories and animal facilities are available for the study of infectious diseases such as tuberculosis and other pulmonary and enteric infections, and more recently COVID-19.
Understanding the functioning of living organisms is the ambition of the Centre for Integrative Biology (CBI) in Toulouse. To achieve this goal, the CBI develops multidisciplinary, multi-scale approaches, from isolated molecules to whole organisms and animal societies, and uses numerous model organisms, from bacteria to humans. At its origin in 2016, the Federation of Research in Fundamental Biology was created under the supervision of the National Centre for Scientific Research (CNRS) and the University Toulouse III-Paul Sabatier (UPS). Today, the CBI brings together more than 400 people, working in 38 research groups, in three laboratories: Microbiology (LMGM), Molecular, Cellular and Developmental Biology (MCD), and Animal Cognition (CRCA). CBI groups, platforms and services are composed of researchers, faculty members, PhD and post-doctoral students, administrative and technical staff, not only from the CNRS, but also from the University and INSERM, making it one of the most important scientific research centres in France.
The Laboratoire de Microbiologie et Genetique Moleculaires (LMGM) is part of the Center for Integrative Biology in Toulouse (CBI Toulouse). We study the organization, evolution and expression of the genomes of bacteria.
The IRSD brings together and structures research forces (6 teams and 2 platforms) around a common goal: to improve understanding of the physiology of the digestive system (intestine and liver). IRSD mission is to conduct medical research, support training through research and disseminate the latest advances and practices in digestive health.
The ‘Toulouse Institute for Infectious and Inflammatory diseases’ (Infinity) results from the merge of two research units localized on the Purpan campus, the CPTP (Center of Pathophysiology of Toulouse-Purpan) and the UDEAR (Epithelial Differentiation and Rheumatoid Autoimmunity Unit). In the past years, strong links between members of the CPTP and the UDEAR emerged in the frame of scientific collaborative works, scientific animations and at the logistic level. This new institute is a leading research institute providing a productive scientific environment that is structured along three main themes: Immunology and Inflammatory and Infectious diseases. Infinity is affiliated with INSERM, CNRS and the University Toulouse III. It is composed of 14 research teams with international reputation, 4 cutting-edge core facilities and an efficient support team (more than 260 total members).
Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. The company has a particular focus on life-threatening respiratory infections, including carbapenem-resistant nosocomial pneumonia and chronic pulmonary diseases. Antabio’s lead program, MEM-ANT3310, is being developed for the treatment of hospital-acquired infections such as nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii (CRAB) and carbapenem-resistant Enterobacterales (CRE).
Responsible for education, professional training and career orientation, the Region is behind innovative initiatives to ensure its 226,000 high school students, 34,000 apprentices and 270,000 students are able to achieve success. Our aim is to guarantee equality of opportunity and optimum educational conditions, while increasing access to training and employment and getting young people involved in regional policies. The Region supports young people by enhancing the diversity and quality of post-high school options on offer. Regional aid also comes in the form of support for research institutions, in order to boost economic development and equality of access to higher education, spreading innovation through every local district, and promoting and enhancing public research
Key Facts: 19,000 students trained for jobs in the aeronautics and space sector per year, 15 competitive clusters, 106 schools offering health and social care training, 3,400 receiving bursaries in the health and social care sector, €5.558 billion invested in research and development, and over 29,400 researchers.
The mission of the National Centre for Scientific Research (CNRS) is to leverage all fields of sciences to tackle current global challenges. The CNRS has over 80 years experience of basic research, exploring living creatures, space, materials and human societies and can leverage all fields of science to understand current global challenges in all their complexity, in conjunction with organisations in the field.
The Federative Research Structure « Biology and Biotechnology for Health » (SFR-B2S) was created in 2023 following the merger of the Toulouse Biomedical Research Federative Structure (SFR-BMT, FED 4138) and the Toulouse Biology Research Federation (SFR-BT, FR 3451). In addition, as part of its unit project, the Toulouse Biotechnology Institute (TBI) has decided to join this new federation, bringing biotechnology within its scope. This federative structure plays an active role in the coordinated dissemination of knowledge and information between the various research centres, in order to maintain a centre of excellence in the field of biology and biotechnologies for health. It is also a driving force behind Génotoul and the BABS cluster at Toulouse III – Paul Sabatier University. By bringing together 15 research institutes of the Toulouse site, its mission is not only to encourage exchanges and interactions between the constituent units, but also to give greater national and international visibility to the high-level research carried out in these units.
A university at the heart of science Our university is named after Paul Sabatier, a French scientist born in Carcassonne in 1854. Paul Sabatier won the Nobel Prize in Chemistry in 1912. He was Dean of the Faculty of Sciences in Toulouse and a member of the Academy of Sciences. The Université Toulouse III – Paul Sabatier has more than 37,000 students and 68 research facilities on its campus. Université Toulouse III – Paul Sabatier has a history dating back to the 13th century and is among some of the oldest universities in the world. It was officially founded in 1969 by a merger between the faculties of Medicine, Pharmaceuticals and Science. Its wide range of laboratories and high quality training courses in the fields of science, health, sport, technology and engineering have earned it the reputation of being one of the world’s leading scientific universities for over 50 years now. It is ranked among the top 300 institutions for its scientific performance in the Academic Ranking of World Universities (ARWU ranking), also known as the Shanghai Ranking.
Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside. It also partners with the most prestigious research institutions in the world that are committed to scientific challenges and progress in these fields. Inserm brings together 15,000 researchers, engineers, technicians and administrative staff, all with one shared objective: improve health by advancing knowledge about living organisms and diseases, developing innovative treatment modalities and conducting research on public health. The institute also maintains a longstanding tradition of European and international cooperation. Every year, our teams report more than 7,000 collaborations with foreign partners, across all research domains in the life and health sciences.